标题
Targeting CD24 as a novel immunotherapy for solid cancers
作者
关键词
-
出版物
Cell Communication and Signaling
Volume 21, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-11-02
DOI
10.1186/s12964-023-01315-w
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- miR‑122/SENP1 axis confers stemness and chemoresistance to liver cancer through Wnt/β‑catenin signaling
- (2023) Jianbo Dai et al. Oncology Letters
- Blockade of novel immune checkpoints and new therapeutic combinations to boost antitumor immunity
- (2022) Adrià Archilla-Ortega et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Biomedical application of small extracellular vesicles in cancer treatment
- (2022) Salome Araujo-Abad et al. ADVANCED DRUG DELIVERY REVIEWS
- Next generation of immune checkpoint molecules in maternal‐fetal immunity*
- (2022) Si‐Jia Zhao et al. IMMUNOLOGICAL REVIEWS
- Efficacy and safety of CD24Fc in hospitalised patients with COVID-19: a randomised, double-blind, placebo-controlled, phase 3 study
- (2022) James Welker et al. LANCET INFECTIOUS DISEASES
- Immune evader cancer stem cells direct the perspective approaches to cancer immunotherapy
- (2022) Hassan Dianat-Moghadam et al. Stem Cell Research & Therapy
- CD24 Is a Potential Immunotherapeutic Target for Mantle Cell Lymphoma
- (2022) Jimena Álvarez Freile et al. Biomedicines
- Unmet Needs in Oncology Clinical Research and Treatment in Africa: Focus on Ghana
- (2022) Lewis R Roberts et al. ONCOLOGIST
- CD24: A Novel Target for Cancer Immunotherapy
- (2022) Emmanouil Panagiotou et al. Journal of Personalized Medicine
- Polysaccharide immunization and colorectal cancer: A systematic review and network meta-analysis
- (2022) Yuefeng Chen et al. Frontiers in Nutrition
- CD24-gold nanocomposite as promising and sensitive biomarker for cancer stem cells in salivary gland tumors
- (2022) Amina Fouad Farag et al. Nanomedicine-Nanotechnology Biology and Medicine
- Drug resistance in NSCLC is associated with tumor micro-environment
- (2022) Weiguo Zhang et al. Reproductive Biology
- The lipid rafts in cancer stem cell: a target to eradicate cancer
- (2022) Shuo Zhang et al. Stem Cell Research & Therapy
- The Proliferative Role of Immune Checkpoints in Tumors: Double Regulation
- (2022) Xi-Yang Tang et al. Cancers
- Engaging stemness improves cancer immunotherapy
- (2022) Hassan Dianat-Moghadam et al. CANCER LETTERS
- Targeting immune checkpoints: how to use natural killer cells for fighting against solid tumors
- (2022) Farhoodeh Ghaedrahmati et al. Cancer Communications
- Keap1-Nrf2 Pathway Regulates ALDH and Contributes to Radioresistance in Breast Cancer Stem Cells
- (2021) Dinisha Kamble et al. Cells
- P-selectin axis plays a key role in microglia immunophenotype and glioblastoma progression
- (2021) Eilam Yeini et al. Nature Communications
- Resolving the spatial and cellular architecture of lung adenocarcinoma by multiregion single-cell sequencing
- (2021) Ansam Sinjab et al. Cancer Discovery
- A Comparative in Silico Analysis of CD24’s Prognostic Value in Human and Canine Prostate Cancer
- (2021) Antonio Fernando Leis-Filho et al. Journal of Personalized Medicine
- CD24 for Cardiovascular Researchers: A Key Molecule in Cardiac Immunology, Marker of Stem Cells and Target for Drug Development
- (2021) Eyal Sagiv et al. Journal of Personalized Medicine
- Simple Cancer Stem Cell Markers Predict Neoadjuvant Chemotherapy Resistance of Esophageal Squamous Cell Carcinoma
- (2021) KYOSUKE AGAWA et al. ANTICANCER RESEARCH
- Glycosylation Modulates Plasma Membrane Trafficking of CD24 in Breast Cancer Cells
- (2021) Amanda Chantziou et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- ELF5 inhibits the proliferation and invasion of breast cancer cells by regulating CD24
- (2021) Xinjian Qu et al. MOLECULAR BIOLOGY REPORTS
- Translocation of intracellular CD24 constitutes a triggering event for drug resistance in breast cancer
- (2021) Hugo Werner Huth et al. Scientific Reports
- Potential Role of CD47-Directed Bispecific Antibodies in Cancer Immunotherapy
- (2021) Yan Yang et al. Frontiers in Immunology
- Feasibly of CD24/CD11b as a Screening Test for Hematological Malignancies
- (2021) Shiran Shapira et al. Journal of Personalized Medicine
- Trans-ethnic genome-wide association study of severe COVID-19
- (2021) Peng Wu et al. Communications Biology
- The impact of DAMP-mediated inflammation in severe COVID-19 and related disorders
- (2021) Upasana Parthasarathy et al. BIOCHEMICAL PHARMACOLOGY
- Single-cell mass cytometry reveals cross-talk between inflammation-dampening and inflammation-amplifying cells in osteoarthritic cartilage
- (2020) Fiorella Carla Grandi et al. Science Advances
- Novel Therapeutic Strategies for Ovarian Cancer Stem Cells
- (2020) Nastassja Terraneo et al. Frontiers in Oncology
- A Dinucleotide Deletion in the CD24 Gene Is a Potential Risk Factor for Colorectal Cancer
- (2020) Lior Segev et al. AMERICAN SURGEON
- CD24, A Review of its Role in Tumor Diagnosis, Progression and Therapy
- (2020) Yang-Hong Ni et al. CURRENT GENE THERAPY
- Novel insights into the function of CD24 : a driving force in cancer
- (2020) Peter Altevogt et al. INTERNATIONAL JOURNAL OF CANCER
- Molecular Mechanism of Tumor Cell Immune Escape Mediated by CD24/Siglec-10
- (2020) Shan-Shan Yin et al. Frontiers in Immunology
- Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies
- (2020) Lia Walcher et al. Frontiers in Immunology
- CD24-targeted intraoperative fluorescence image-guided surgery leads to improved cytoreduction of ovarian cancer in a preclinical orthotopic surgical model
- (2020) Katrin Kleinmanns et al. EBioMedicine
- CD24, not CD47, negatively impacts upon response to PD‐1/L1 inhibitors in non‐small cell lung cancer with PD‐L1 TPS
- (2020) Yuichi Ozawa et al. CANCER SCIENCE
- Cancer and the Microbiome—Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy
- (2020) Vyara Matson et al. GASTROENTEROLOGY
- The Emerging Role of CD24 in Cancer Theranostics—A Novel Target for Fluorescence Image-Guided Surgery in Ovarian Cancer and Beyond
- (2020) Katrin Kleinmanns et al. Journal of Personalized Medicine
- Anti-CD24 antibody-nitric oxide conjugate (ANC) selectively and potently suppresses hepatic carcinoma
- (2019) Fumou Sun et al. CANCER RESEARCH
- Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer
- (2019) Shangze Li et al. CANCER RESEARCH
- Heparanase promotes glioma progression via enhancing CD24 expression
- (2019) Uri Barash et al. INTERNATIONAL JOURNAL OF CANCER
- CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy
- (2019) Amira A. Barkal et al. NATURE
- T cells expressing NKG2D chimeric antigen receptors efficiently eliminate glioblastoma and cancer stem cells
- (2019) Dong Yang et al. Journal for ImmunoTherapy of Cancer
- Presence and role of stem cells in ovarian cancer
- (2019) Natasa Kenda Suster et al. World Journal of Stem Cells
- The role of CD24 in multiple myeloma tumorigenicity and effects of the microenvironment on its expression
- (2019) Nechama Gilad et al. Oncotarget
- MicroRNA‐3064‐5p sponged by MALAT1 suppresses angiogenesis in human hepatocellular carcinoma by targeting the FOXA1/CD24/Src pathway
- (2019) Pei Zhang et al. FASEB JOURNAL
- GD2-targeted chimeric antigen receptor T cells prevent metastasis formation by elimination of breast cancer stem-like cells
- (2019) Christian M. Seitz et al. OncoImmunology
- Inhibition of Elevated Hippocampal CD24 Reduces Neurogenesis in Mice With Traumatic Brain Injury
- (2019) Han Wang et al. JOURNAL OF SURGICAL RESEARCH
- Involvement of CD24 in Multiple Cancer Related Pathways Makes It an Interesting New Target for Cancer Therapy
- (2018) Shirin Eyvazi et al. CURRENT CANCER DRUG TARGETS
- Cancer stem cells-emanated therapy resistance: Implications for liposomal drug delivery systems
- (2018) Hassan Dianat-Moghadam et al. JOURNAL OF CONTROLLED RELEASE
- Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance
- (2018) Piyush B. Gupta et al. Cell Stem Cell
- Molecular Profiling of Cohorts of Tumor Samples to Guide Clinical Development of Pembrolizumab as Monotherapy
- (2018) Mark Ayers et al. CLINICAL CANCER RESEARCH
- Pembrolizumab in patients with programmed death ligand 1–positive advanced ovarian cancer: Analysis of KEYNOTE-028
- (2018) Andrea Varga et al. GYNECOLOGIC ONCOLOGY
- Cancer stem cells (CSCs) in cancer progression and therapy
- (2018) Masoud Najafi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Overview of CD24 as a new molecular marker in ovarian cancer
- (2018) Vahideh Tarhriz et al. JOURNAL OF CELLULAR PHYSIOLOGY
- iNOS promotes CD24+CD133+ liver cancer stem cell phenotype through a TACE/ADAM17-dependent Notch signaling pathway
- (2018) Ronghua Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
- (2017) Sydney R. Gordon et al. NATURE
- The CD24 surface antigen in neural development and disease
- (2017) Daniel T. Gilliam et al. NEUROBIOLOGY OF DISEASE
- CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways
- (2017) Kiyoko Nakamura et al. ONCOLOGY REPORTS
- CD24 Expression and differential resistance to chemotherapy in triple-negative breast cancer
- (2017) Xinyu Deng et al. Oncotarget
- Hedgehog signaling pathway regulates ovarian cancer invasion and migration via adhesion molecule CD24
- (2017) Chunyan Zeng et al. Journal of Cancer
- PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
- (2017) Hashem O. Alsaab et al. Frontiers in Pharmacology
- CD24 suppresses malignant phenotype by downregulation of SHH transcription through STAT1 inhibition in breast cancer cells
- (2016) Kumi Suyama et al. CANCER LETTERS
- Cancer stem cells, cancer-initiating cells and methods for their detection
- (2016) Shiva Akbari-Birgani et al. DRUG DISCOVERY TODAY
- Both bulk and cancer stem cell subpopulations in triple-negative breast cancer are susceptible to Wnt, HDAC, and ERα coinhibition
- (2016) Andrew Sulaiman et al. FEBS LETTERS
- Expression of CD24 and Siglec-10 in first trimester placenta: implications for immune tolerance at the fetal–maternal interface
- (2016) Marei Sammar et al. HISTOCHEMISTRY AND CELL BIOLOGY
- CD24 is highly useful in differentiating high-grade serous carcinoma from benign and malignant mesothelial cells
- (2016) Ben Davidson HUMAN PATHOLOGY
- Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study
- (2016) Rita Nanda et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer stem cell signaling pathways
- (2016) William H. Matsui MEDICINE
- The Hedgehog signaling pathway is associated with poor prognosis in breast cancer patients with the CD44+/CD24− phenotype
- (2016) Haishan Zhao et al. Molecular Medicine Reports
- Wnt signaling in cancer
- (2016) T Zhan et al. ONCOGENE
- Wnt Signaling in Cancer Stem Cell Biology
- (2016) Felipe de Sousa e Melo et al. Cancers
- Terpinen-4-ol: A Novel and Promising Therapeutic Agent for Human Gastrointestinal Cancers
- (2016) Shiran Shapira et al. PLoS One
- PI3K/Akt/mTOR pathway dual inhibitor BEZ235 suppresses the stemness of colon cancer stem cells
- (2015) Jiezhong Chen et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- CD24+ Ovarian Cancer Cells Are Enriched for Cancer-Initiating Cells and Dependent on JAK2 Signaling for Growth and Metastasis
- (2015) D. Burgos-Ojeda et al. MOLECULAR CANCER THERAPEUTICS
- CD24 Overexpression Is Associated with Poor Prognosis in Luminal A and Triple-Negative Breast Cancer
- (2015) Mi Jeong Kwon et al. PLoS One
- CD24 promotes HCC progression via triggering Notch-related EMT and modulation of tumor microenvironment
- (2015) Xin Wan et al. TUMOR BIOLOGY
- Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells
- (2015) Ronghua Wang et al. Oncotarget
- Leishmania infantum Amastigotes Trigger a Subpopulation of Human B Cells with an Immunoregulatory Phenotype
- (2015) Guadalupe Andreani et al. PLoS Neglected Tropical Diseases
- CD24 regulates stemness and the epithelial to mesenchymal transition through modulation of Notch1 mRNA stability by p38MAPK
- (2014) Juyeon Lim et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Expression of CD24 is associated with HER2 expression and supports HER2-Akt signaling in HER2-positive breast cancer cells
- (2014) Mari Hosonaga et al. CANCER SCIENCE
- The effects of STAT3 and Survivin silencing on the growth of human bladder carcinoma cells
- (2014) Baogang Zhang et al. TUMOR BIOLOGY
- PTEN deficiency is associated with reduced sensitivity to mTOR inhibitor in human bladder cancer through the unhampered feedback loop driving PI3K/Akt activation
- (2013) E Seront et al. BRITISH JOURNAL OF CANCER
- The immunohistochemical expression of CD24 and CD171 adhesion molecules in borderline ovarian tumors
- (2013) Alexandra Moulla et al. POLISH JOURNAL OF PATHOLOGY
- Urothelial tumor initiation requires deregulation of multiple signaling pathways: implications in target-based therapies
- (2012) H. Zhou et al. CARCINOGENESIS
- CD24 controls Src/STAT3 activity in human tumors
- (2012) Niko P. Bretz et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- CD44+/CD24− ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival
- (2012) Erhong Meng et al. CLINICAL & EXPERIMENTAL METASTASIS
- Targeting Stat3 Abrogates EGFR Inhibitor Resistance in Cancer
- (2012) M. Sen et al. CLINICAL CANCER RESEARCH
- Lyn is involved in CD24-induced ERK1/2 activation in colorectal cancer
- (2012) Ning Su et al. Molecular Cancer
- Intracellular CD24 Inhibits Cell Invasion by Posttranscriptional Regulation of BART through Interaction with G3BP
- (2011) K. Taniuchi et al. CANCER RESEARCH
- CD24 interacts with and promotes the activity of c-src within lipid rafts in breast cancer cells, thereby increasing integrin-dependent adhesion
- (2011) Petra Baumann et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype
- (2011) S. Ricardo et al. JOURNAL OF CLINICAL PATHOLOGY
- Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways
- (2011) Siyuan Zhang et al. NATURE MEDICINE
- Regulation of Breast Cancer Stem Cell Activity by Signaling through the Notch4 Receptor
- (2010) H. Harrison et al. CANCER RESEARCH
- CD24: from A to Z
- (2010) Xianfeng Fang et al. Cellular & Molecular Immunology
- Targeting Notch to Target Cancer Stem Cells
- (2010) A. Pannuti et al. CLINICAL CANCER RESEARCH
- Molecular and clinical dissection of CD24 antibody specificity by a comprehensive comparative analysis
- (2010) Glen Kristiansen et al. LABORATORY INVESTIGATION
- CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells
- (2010) M-Q Gao et al. ONCOGENE
- A Novel Splice Variant of GLI1 That Promotes Glioblastoma Cell Migration and Invasion
- (2009) H.-W. Lo et al. CANCER RESEARCH
- CD24-dependent MAPK pathway activation is required for colorectal cancer cell proliferation
- (2009) Weifei Wang et al. CANCER SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search